Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market
Holding PBLA?
Track your performance easily

Panbela Therapeutics (PBLA) Income Statement

242 Followers

Panbela Therapeutics Income Statement

Last quarter (Q2 2024), Panbela Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Panbela Therapeutics's net income was $-7.14M. See Panbela Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 27.77M$ 25.65M$ 34.09M$ 10.01M$ 5.75M$ 4.32M
Operating Income
$ -27.77M$ -25.65M$ -34.09M$ -10.01M$ -5.75M$ -4.32M
Net Non Operating Interest Income Expense
$ -79.00K$ -194.00K$ -274.00K$ -11.00K$ -17.00K$ -2.19M
Other Income Expense
$ -311.00K$ 392.00K$ -682.00K$ 602.00K$ -708.00K$ 99.00K
Pretax Income
$ -26.88M$ -25.45M$ -35.05M$ -10.62M$ -5.06M$ -6.62M
Tax Provision
$ -304.00K$ -186.00K$ -116.00K$ -488.00K$ -295.00K$ -415.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -26.57M$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Basic EPS
$ 126.44$ -316.52$ -40.75K$ -20.88K$ -14.88K-
Diluted EPS
$ 126.44$ -316.52$ -40.75K$ -20.88K$ -14.88K$ -32.70
Basic Average Shares
$ 8.26M$ 108.69K$ 857.00$ 487.00$ 322.00$ 190.01K
Diluted Average Shares
$ 8.26M$ 108.69K$ 857.00$ 487.00$ 322.00$ 190.01K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 27.77M$ 25.65M$ 34.09M$ 10.01M$ 5.75M$ 4.32M
Net Income From Continuing And Discontinued Operation
$ -26.57M$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Normalized Income
$ -13.59M$ -25.64M----
Interest Expense
------
EBIT
$ -26.73M$ -25.13M$ -34.76M$ -10.61M$ -5.05M$ -4.42M
EBITDA
$ -26.73M$ -25.13M$ -34.76M$ -10.61M$ -5.05M$ -2.34M
Currency in USD

Panbela Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis